Literature DB >> 10644835

Mapping of immunodominant B-cell epitopes and the human serum albumin-binding site in natural hepatitis B virus surface antigen of defined genosubtype.

D Sobotta1, I Sominskaya, J Jansons, H Meisel, S Schmitt, K H Heermann, G Kaluza, P Pumpens, W H Gerlich.   

Abstract

Twelve MAbs were generated by immunization of BALB/c mice with plasma-derived hepatitis B virus surface spherical antigen particles subtype ayw2 (HBsAg/ayw2 genotype D). Their epitopes were mapped by analysis of reactivity with plasma-derived HBsAg/ayw2 and HBsAg/adw2 (genotype A) in enzyme immunoassays and blots. Mapping was supported by nested sets of truncated preS2 proteins and preS2 peptides. Five antibodies were S domain-specific, seven were preS2-specific and 11 had a preference for genotype D. According to our data, group I of the three known epitope groups of preS2 has to be divided into IA and IB. Three preS2-specific MAbs forming the new group IA reacted with genotype D residues 3-15 which have not yet been described as an epitope region. IA antibodies strongly inhibited the binding of polymerized human serum albumin. Two antibodies (group II) reacted with the glycosylated N-terminal region of preS2 in plasma-derived HBsAg, but not with a preparation from transfected murine cells. One group III antibody was subtype-specific and reacted with the highly variable preS2 sequence 38-48. Only one antibody (group IB) mapped to the region (old group I) which was believed to be immunodominant and genotype-independent. Geno(sub)type-specific epitopes of preS2 are obviously the immunodominant components of natural HBsAg in BALB/c mice, but these epitopes may be masked by serum albumins in humans. The data may explain why it is difficult to detect anti-preS2 antibodies in human recipients of preS2-containing vaccines, in spite of the preS2 immunodominance in mice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644835     DOI: 10.1099/0022-1317-81-2-369

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  11 in total

1.  The design and implementation of the immune epitope database and analysis resource.

Authors:  Bjoern Peters; John Sidney; Phil Bourne; Huynh-Hoa Bui; Soeren Buus; Grace Doh; Ward Fleri; Mitch Kronenberg; Ralph Kubo; Ole Lund; David Nemazee; Julia V Ponomarenko; Muthu Sathiamurthy; Stephen P Schoenberger; Scott Stewart; Pamela Surko; Scott Way; Steve Wilson; Alessandro Sette
Journal:  Immunogenetics       Date:  2005-05-14       Impact factor: 2.846

Review 2.  Viral and cellular determinants involved in hepadnaviral entry.

Authors:  Dieter Glebe; Stephan Urban
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

3.  Identification of Two Critical Neutralizing Epitopes in the Receptor Binding Domain of Hepatitis B Virus preS1.

Authors:  Keigo Yato; Taishi Onodera; Mami Matsuda; Saya Moriyama; Akira Fujimoto; Koichi Watashi; Hideki Aizaki; Tomohisa Tanaka; Kohji Moriishi; Hironori Nishitsuji; Kunitada Shimotohno; Koji Tamura; Yoshimasa Takahashi; Takaji Wakita; Masamichi Muramatsu; Takanobu Kato; Ryosuke Suzuki
Journal:  J Virol       Date:  2020-12-09       Impact factor: 5.103

Review 4.  Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives.

Authors:  Wolfram H Gerlich
Journal:  Med Microbiol Immunol       Date:  2014-12-19       Impact factor: 3.402

5.  Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus.

Authors:  Dieter Glebe; Mehriar Aliakbari; Peter Krass; Eva V Knoop; Klaus P Valerius; Wolfram H Gerlich
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

6.  Modification of the hepatitis B virus envelope protein glycosylation pattern interferes with secretion of viral particles, infectivity, and susceptibility to neutralizing antibodies.

Authors:  Romain Julithe; Georges Abou-Jaoudé; Camille Sureau
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

7.  Functional analysis of hepatitis B virus pre-s deletion variants associated with hepatocellular carcinoma.

Authors:  Chih-Ming Lin; Gen-Ming Wang; Guey-Mei Jow; Bing-Fang Chen
Journal:  J Biomed Sci       Date:  2012-02-07       Impact factor: 8.410

8.  Evolutionary Changes of Hepatitis B Virus Pre-S Mutations Prior to Development of Hepatocellular Carcinoma.

Authors:  An-Ye Zhang; Ching-Lung Lai; Fung-Yu Huang; Wai-Kay Seto; James Fung; Danny Ka-Ho Wong; Man-Fung Yuen
Journal:  PLoS One       Date:  2015-09-30       Impact factor: 3.240

Review 9.  Hepatitis B virus pre-S/S variants in liver diseases.

Authors:  Bing-Fang Chen
Journal:  World J Gastroenterol       Date:  2018-04-14       Impact factor: 5.742

10.  Different pre-S deletion patterns and their association with hepatitis B virus genotypes.

Authors:  Bing-Fang Chen
Journal:  World J Gastroenterol       Date:  2016-09-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.